AAAAAA

   
Results: 1-7 |
Results: 7
T-CELLS INFILTRATING THE SKIN OF TSK2 SCLERODERMA-LIKE MICE EXHIBIT T-CELL RECEPTOR BIAS
Authors: WOOLEY PH SUD S LANGENDORFER A CALKINS C CHRISTNER PJ PETERS J JIMENEZ SA
Citation: Ph. Wooley et al., T-CELLS INFILTRATING THE SKIN OF TSK2 SCLERODERMA-LIKE MICE EXHIBIT T-CELL RECEPTOR BIAS, Autoimmunity, 27(2), 1998, pp. 91-98
PRIMARY PREVENTION OF ACUTE CORONARY EVENTS WITH LOVASTATIN IN MEN AND WOMEN WITH AVERAGE CHOLESTEROL LEVELS - RESULTS OF AFCAPS TEXCAPS/
Authors: DOWNS JR CLEARFIELD M WEIS S WHITNEY E SHAPIRO DR BEERE PA LANGENDORFER A STEIN EA KRUYER W GOTTO AM
Citation: Jr. Downs et al., PRIMARY PREVENTION OF ACUTE CORONARY EVENTS WITH LOVASTATIN IN MEN AND WOMEN WITH AVERAGE CHOLESTEROL LEVELS - RESULTS OF AFCAPS TEXCAPS/, JAMA, the journal of the American Medical Association, 279(20), 1998, pp. 1615-1622
DESIGN AND RATIONALE OF THE AIR-FORCE TEXAS CORONARY ATHEROSCLEROSIS PREVENTION STUDY (AFCAP TEXCAPS)/
Authors: DOWNS JR BEERE PA WHITNEY E CLEARFIELD M WEIS S ROCHEN J STEIN EA SHAPIRO DR LANGENDORFER A GOTTO AM
Citation: Jr. Downs et al., DESIGN AND RATIONALE OF THE AIR-FORCE TEXAS CORONARY ATHEROSCLEROSIS PREVENTION STUDY (AFCAP TEXCAPS)/, The American journal of cardiology, 80(3), 1997, pp. 287-293
EFFICACY AND TOLERABILITY OF LOVASTATIN IN 459 AFRICAN-AMERICANS WITHHYPERCHOLESTEROLEMIA
Authors: PRISANT LM DOWNTON M WATKINS LO SCHNAPER H BRADFORD RH CHREMOS AN LANGENDORFER A
Citation: Lm. Prisant et al., EFFICACY AND TOLERABILITY OF LOVASTATIN IN 459 AFRICAN-AMERICANS WITHHYPERCHOLESTEROLEMIA, The American journal of cardiology, 78(4), 1996, pp. 420-424
T-CELLS INFILTRATING THE SKIN OF TSK-2 SCLERODERMA-LIKE MICE EXHIBIT T-CELL RECEPTOR BIAS
Authors: WOOLEY PH SUD S LANGENDORFER A CALKINS C CHRISTNER PJ JIMENEZ SA
Citation: Ph. Wooley et al., T-CELLS INFILTRATING THE SKIN OF TSK-2 SCLERODERMA-LIKE MICE EXHIBIT T-CELL RECEPTOR BIAS, Arthritis and rheumatism, 38(9), 1995, pp. 600-600
EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS - 2-YEAR EFFICACY AND SAFETY FOLLOW-UP
Authors: BRADFORD RH SHEAR CL CHREMOS AN DUJOVNE CA FRANKLIN FA GRILLO RB HIGGINS J LANGENDORFER A NASH DT POOL JL SCHNAPER H
Citation: Rh. Bradford et al., EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS - 2-YEAR EFFICACY AND SAFETY FOLLOW-UP, The American journal of cardiology, 74(7), 1994, pp. 667-673
EFFICACY AND TOLERABILITY OF LOVASTATIN IN 3390 WOMEN WITH MODERATE HYPERCHOLESTEROLEMIA
Authors: BRADFORD RH DOWNTON M CHREMOS AN LANGENDORFER A STINNETT S NASH DT MANTELL G SHEAR CL
Citation: Rh. Bradford et al., EFFICACY AND TOLERABILITY OF LOVASTATIN IN 3390 WOMEN WITH MODERATE HYPERCHOLESTEROLEMIA, Annals of internal medicine, 118(11), 1993, pp. 850-855
Risultati: 1-7 |